At this time, posts about Hyundai Pharm are rapidly increasing on portals and stock communities, with foreign investors tentatively reported to have net purchased 11,000 shares today. Hyundai Pharm is known as a manufacturer of health beverages such as Miero Fiber and pharmaceuticals.


As of 12:30 PM on the 24th, Hyundai Pharm's stock price is 7,670 KRW, down 5.54% from the previous day, with a trading volume of 6,495,929 shares, which is about 20.54% of the 5-day average trading volume. On December 23rd, Hyundai Pharm was an issue in the market as it "continued the previous day's upper limit price surge."


In addition to Hyundai Pharm, posts by investors are also rapidly increasing regarding Sellmate Therapeutics (015540), Moatech (033200), and KMH (122450).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing